nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ADRB2—ulcerative colitis	0.493	0.687	CbGaD
Nadolol—ABCB1—ulcerative colitis	0.225	0.313	CbGaD
Nadolol—ABCB1—Methylprednisolone—ulcerative colitis	0.0295	0.257	CbGbCtD
Nadolol—ABCB1—Betamethasone—ulcerative colitis	0.0192	0.167	CbGbCtD
Nadolol—ABCB1—Prednisolone—ulcerative colitis	0.0189	0.165	CbGbCtD
Nadolol—ABCB1—Hydrocortisone—ulcerative colitis	0.0179	0.157	CbGbCtD
Nadolol—ABCB1—Prednisone—ulcerative colitis	0.0179	0.156	CbGbCtD
Nadolol—ABCB1—Dexamethasone—ulcerative colitis	0.0112	0.0974	CbGbCtD
Nadolol—Pirbuterol—ADRB2—ulcerative colitis	0.00127	0.204	CrCbGaD
Nadolol—Levobunolol—ADRB2—ulcerative colitis	0.00113	0.181	CrCbGaD
Nadolol—Carteolol—ADRB2—ulcerative colitis	0.000959	0.154	CrCbGaD
Nadolol—Bupranolol—ADRB2—ulcerative colitis	0.000815	0.131	CrCbGaD
Nadolol—Salbutamol—ADRB2—ulcerative colitis	0.000767	0.123	CrCbGaD
Nadolol—Penbutolol—ADRB2—ulcerative colitis	0.000746	0.12	CrCbGaD
Nadolol—Pindolol—ADRB2—ulcerative colitis	0.000538	0.0865	CrCbGaD
Nadolol—Rash—Mercaptopurine—ulcerative colitis	0.000281	0.00193	CcSEcCtD
Nadolol—Dermatitis—Mercaptopurine—ulcerative colitis	0.00028	0.00193	CcSEcCtD
Nadolol—Bronchospasm—Methylprednisolone—ulcerative colitis	0.000279	0.00192	CcSEcCtD
Nadolol—Vision blurred—Mesalazine—ulcerative colitis	0.000279	0.00192	CcSEcCtD
Nadolol—Amnesia—Prednisone—ulcerative colitis	0.000277	0.00191	CcSEcCtD
Nadolol—Weight increased—Hydrocortisone—ulcerative colitis	0.000275	0.00189	CcSEcCtD
Nadolol—Vomiting—Nicotine—ulcerative colitis	0.000274	0.00189	CcSEcCtD
Nadolol—Dry skin—Betamethasone—ulcerative colitis	0.000274	0.00189	CcSEcCtD
Nadolol—Dry skin—Dexamethasone—ulcerative colitis	0.000274	0.00189	CcSEcCtD
Nadolol—Rash—Nicotine—ulcerative colitis	0.000272	0.00187	CcSEcCtD
Nadolol—Dermatitis—Nicotine—ulcerative colitis	0.000272	0.00187	CcSEcCtD
Nadolol—Insomnia—Budesonide—ulcerative colitis	0.000269	0.00185	CcSEcCtD
Nadolol—Conjunctivitis—Prednisolone—ulcerative colitis	0.000268	0.00185	CcSEcCtD
Nadolol—Paraesthesia—Budesonide—ulcerative colitis	0.000267	0.00184	CcSEcCtD
Nadolol—Cardiac failure—Prednisone—ulcerative colitis	0.000267	0.00184	CcSEcCtD
Nadolol—Syncope—Mesalazine—ulcerative colitis	0.000266	0.00183	CcSEcCtD
Nadolol—Lethargy—Prednisone—ulcerative colitis	0.000265	0.00183	CcSEcCtD
Nadolol—Dyspnoea—Budesonide—ulcerative colitis	0.000265	0.00182	CcSEcCtD
Nadolol—Nausea—Mercaptopurine—ulcerative colitis	0.000264	0.00182	CcSEcCtD
Nadolol—Dyspepsia—Budesonide—ulcerative colitis	0.000262	0.0018	CcSEcCtD
Nadolol—Loss of consciousness—Mesalazine—ulcerative colitis	0.00026	0.00179	CcSEcCtD
Nadolol—Weight increased—Triamcinolone—ulcerative colitis	0.000259	0.00178	CcSEcCtD
Nadolol—Cough—Mesalazine—ulcerative colitis	0.000258	0.00178	CcSEcCtD
Nadolol—Weight increased—Methylprednisolone—ulcerative colitis	0.000258	0.00178	CcSEcCtD
Nadolol—Decreased appetite—Budesonide—ulcerative colitis	0.000258	0.00178	CcSEcCtD
Nadolol—Nausea—Nicotine—ulcerative colitis	0.000256	0.00176	CcSEcCtD
Nadolol—Fatigue—Budesonide—ulcerative colitis	0.000256	0.00176	CcSEcCtD
Nadolol—Affect lability—Prednisone—ulcerative colitis	0.000256	0.00176	CcSEcCtD
Nadolol—Hypertension—Mesalazine—ulcerative colitis	0.000256	0.00176	CcSEcCtD
Nadolol—Constipation—Budesonide—ulcerative colitis	0.000254	0.00175	CcSEcCtD
Nadolol—Pain—Budesonide—ulcerative colitis	0.000254	0.00175	CcSEcCtD
Nadolol—Bradycardia—Prednisolone—ulcerative colitis	0.000252	0.00174	CcSEcCtD
Nadolol—Chest pain—Mesalazine—ulcerative colitis	0.000252	0.00174	CcSEcCtD
Nadolol—Irritability—Prednisone—ulcerative colitis	0.000248	0.00171	CcSEcCtD
Nadolol—Hypotension—Azathioprine—ulcerative colitis	0.000248	0.00171	CcSEcCtD
Nadolol—Conjunctivitis—Triamcinolone—ulcerative colitis	0.000247	0.0017	CcSEcCtD
Nadolol—Dry mouth—Mesalazine—ulcerative colitis	0.000247	0.0017	CcSEcCtD
Nadolol—Mood swings—Prednisone—ulcerative colitis	0.000246	0.0017	CcSEcCtD
Nadolol—Bradycardia—Hydrocortisone—ulcerative colitis	0.000246	0.0017	CcSEcCtD
Nadolol—Sweating—Methylprednisolone—ulcerative colitis	0.000243	0.00167	CcSEcCtD
Nadolol—Oedema—Mesalazine—ulcerative colitis	0.000242	0.00166	CcSEcCtD
Nadolol—Hallucination—Hydrocortisone—ulcerative colitis	0.000241	0.00166	CcSEcCtD
Nadolol—Visual impairment—Prednisolone—ulcerative colitis	0.000239	0.00164	CcSEcCtD
Nadolol—Dry skin—Prednisone—ulcerative colitis	0.000238	0.00164	CcSEcCtD
Nadolol—Shock—Mesalazine—ulcerative colitis	0.000238	0.00164	CcSEcCtD
Nadolol—Weight increased—Dexamethasone—ulcerative colitis	0.000235	0.00162	CcSEcCtD
Nadolol—Weight increased—Betamethasone—ulcerative colitis	0.000235	0.00162	CcSEcCtD
Nadolol—Body temperature increased—Budesonide—ulcerative colitis	0.000235	0.00162	CcSEcCtD
Nadolol—Hyperhidrosis—Mesalazine—ulcerative colitis	0.000234	0.00161	CcSEcCtD
Nadolol—Bradycardia—Triamcinolone—ulcerative colitis	0.000232	0.0016	CcSEcCtD
Nadolol—Bradycardia—Methylprednisolone—ulcerative colitis	0.000231	0.00159	CcSEcCtD
Nadolol—Anorexia—Mesalazine—ulcerative colitis	0.00023	0.00159	CcSEcCtD
Nadolol—Abdominal distension—Prednisone—ulcerative colitis	0.000226	0.00156	CcSEcCtD
Nadolol—Hallucination—Methylprednisolone—ulcerative colitis	0.000226	0.00156	CcSEcCtD
Nadolol—Hypotension—Mesalazine—ulcerative colitis	0.000226	0.00155	CcSEcCtD
Nadolol—Conjunctivitis—Betamethasone—ulcerative colitis	0.000224	0.00154	CcSEcCtD
Nadolol—Conjunctivitis—Dexamethasone—ulcerative colitis	0.000224	0.00154	CcSEcCtD
Nadolol—Visual impairment—Methylprednisolone—ulcerative colitis	0.000219	0.00151	CcSEcCtD
Nadolol—Insomnia—Mesalazine—ulcerative colitis	0.000219	0.00151	CcSEcCtD
Nadolol—Paraesthesia—Mesalazine—ulcerative colitis	0.000217	0.00149	CcSEcCtD
Nadolol—Dyspnoea—Mesalazine—ulcerative colitis	0.000215	0.00148	CcSEcCtD
Nadolol—Asthenia—Budesonide—ulcerative colitis	0.000213	0.00147	CcSEcCtD
Nadolol—Dyspepsia—Mesalazine—ulcerative colitis	0.000213	0.00146	CcSEcCtD
Nadolol—Bradycardia—Dexamethasone—ulcerative colitis	0.00021	0.00145	CcSEcCtD
Nadolol—Bradycardia—Betamethasone—ulcerative colitis	0.00021	0.00145	CcSEcCtD
Nadolol—Pruritus—Budesonide—ulcerative colitis	0.00021	0.00145	CcSEcCtD
Nadolol—Decreased appetite—Mesalazine—ulcerative colitis	0.00021	0.00145	CcSEcCtD
Nadolol—Body temperature increased—Azathioprine—ulcerative colitis	0.00021	0.00144	CcSEcCtD
Nadolol—Fatigue—Mesalazine—ulcerative colitis	0.000208	0.00143	CcSEcCtD
Nadolol—Erectile dysfunction—Prednisone—ulcerative colitis	0.000207	0.00143	CcSEcCtD
Nadolol—Pain—Mesalazine—ulcerative colitis	0.000207	0.00142	CcSEcCtD
Nadolol—Constipation—Mesalazine—ulcerative colitis	0.000207	0.00142	CcSEcCtD
Nadolol—Hallucination—Dexamethasone—ulcerative colitis	0.000206	0.00142	CcSEcCtD
Nadolol—Hallucination—Betamethasone—ulcerative colitis	0.000206	0.00142	CcSEcCtD
Nadolol—Weight increased—Prednisone—ulcerative colitis	0.000205	0.00141	CcSEcCtD
Nadolol—Diarrhoea—Budesonide—ulcerative colitis	0.000203	0.0014	CcSEcCtD
Nadolol—Vision blurred—Prednisolone—ulcerative colitis	0.000203	0.0014	CcSEcCtD
Nadolol—Depression—Prednisone—ulcerative colitis	0.0002	0.00138	CcSEcCtD
Nadolol—Visual impairment—Betamethasone—ulcerative colitis	0.000199	0.00137	CcSEcCtD
Nadolol—Visual impairment—Dexamethasone—ulcerative colitis	0.000199	0.00137	CcSEcCtD
Nadolol—Dizziness—Budesonide—ulcerative colitis	0.000196	0.00135	CcSEcCtD
Nadolol—Syncope—Prednisolone—ulcerative colitis	0.000193	0.00133	CcSEcCtD
Nadolol—Body temperature increased—Mesalazine—ulcerative colitis	0.000191	0.00132	CcSEcCtD
Nadolol—Loss of consciousness—Prednisolone—ulcerative colitis	0.000189	0.0013	CcSEcCtD
Nadolol—Vomiting—Budesonide—ulcerative colitis	0.000189	0.0013	CcSEcCtD
Nadolol—Syncope—Hydrocortisone—ulcerative colitis	0.000189	0.0013	CcSEcCtD
Nadolol—Rash—Budesonide—ulcerative colitis	0.000187	0.00129	CcSEcCtD
Nadolol—Dermatitis—Budesonide—ulcerative colitis	0.000187	0.00129	CcSEcCtD
Nadolol—Hypertension—Prednisolone—ulcerative colitis	0.000186	0.00128	CcSEcCtD
Nadolol—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000185	0.00127	CcSEcCtD
Nadolol—Bradycardia—Prednisone—ulcerative colitis	0.000183	0.00126	CcSEcCtD
Nadolol—Alopecia—Dexamethasone—ulcerative colitis	0.000183	0.00126	CcSEcCtD
Nadolol—Alopecia—Betamethasone—ulcerative colitis	0.000183	0.00126	CcSEcCtD
Nadolol—Hypertension—Hydrocortisone—ulcerative colitis	0.000182	0.00125	CcSEcCtD
Nadolol—Diarrhoea—Azathioprine—ulcerative colitis	0.000182	0.00125	CcSEcCtD
Nadolol—Hallucination—Prednisone—ulcerative colitis	0.000179	0.00123	CcSEcCtD
Nadolol—Syncope—Triamcinolone—ulcerative colitis	0.000178	0.00122	CcSEcCtD
Nadolol—Syncope—Methylprednisolone—ulcerative colitis	0.000177	0.00122	CcSEcCtD
Nadolol—Nausea—Budesonide—ulcerative colitis	0.000176	0.00122	CcSEcCtD
Nadolol—Oedema—Prednisolone—ulcerative colitis	0.000176	0.00121	CcSEcCtD
Nadolol—Dizziness—Azathioprine—ulcerative colitis	0.000175	0.00121	CcSEcCtD
Nadolol—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000174	0.0012	CcSEcCtD
Nadolol—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000174	0.0012	CcSEcCtD
Nadolol—Asthenia—Mesalazine—ulcerative colitis	0.000173	0.00119	CcSEcCtD
Nadolol—Shock—Prednisolone—ulcerative colitis	0.000173	0.00119	CcSEcCtD
Nadolol—Cough—Triamcinolone—ulcerative colitis	0.000173	0.00119	CcSEcCtD
Nadolol—Oedema—Hydrocortisone—ulcerative colitis	0.000172	0.00118	CcSEcCtD
Nadolol—Hypertension—Triamcinolone—ulcerative colitis	0.000171	0.00118	CcSEcCtD
Nadolol—Pruritus—Mesalazine—ulcerative colitis	0.000171	0.00118	CcSEcCtD
Nadolol—Hypertension—Methylprednisolone—ulcerative colitis	0.000171	0.00118	CcSEcCtD
Nadolol—Hyperhidrosis—Prednisolone—ulcerative colitis	0.00017	0.00117	CcSEcCtD
Nadolol—Shock—Hydrocortisone—ulcerative colitis	0.000169	0.00116	CcSEcCtD
Nadolol—Vomiting—Azathioprine—ulcerative colitis	0.000169	0.00116	CcSEcCtD
Nadolol—Rash—Azathioprine—ulcerative colitis	0.000167	0.00115	CcSEcCtD
Nadolol—Dermatitis—Azathioprine—ulcerative colitis	0.000167	0.00115	CcSEcCtD
Nadolol—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000166	0.00114	CcSEcCtD
Nadolol—Diarrhoea—Mesalazine—ulcerative colitis	0.000165	0.00114	CcSEcCtD
Nadolol—Dry mouth—Triamcinolone—ulcerative colitis	0.000165	0.00114	CcSEcCtD
Nadolol—Anorexia—Hydrocortisone—ulcerative colitis	0.000164	0.00113	CcSEcCtD
Nadolol—Oedema—Triamcinolone—ulcerative colitis	0.000162	0.00111	CcSEcCtD
Nadolol—Syncope—Betamethasone—ulcerative colitis	0.000161	0.00111	CcSEcCtD
Nadolol—Syncope—Dexamethasone—ulcerative colitis	0.000161	0.00111	CcSEcCtD
Nadolol—Hypotension—Hydrocortisone—ulcerative colitis	0.000161	0.00111	CcSEcCtD
Nadolol—Dizziness—Mesalazine—ulcerative colitis	0.00016	0.0011	CcSEcCtD
Nadolol—Shock—Triamcinolone—ulcerative colitis	0.000159	0.0011	CcSEcCtD
Nadolol—Insomnia—Prednisolone—ulcerative colitis	0.000159	0.0011	CcSEcCtD
Nadolol—Alopecia—Prednisone—ulcerative colitis	0.000159	0.0011	CcSEcCtD
Nadolol—Shock—Methylprednisolone—ulcerative colitis	0.000159	0.00109	CcSEcCtD
Nadolol—Loss of consciousness—Betamethasone—ulcerative colitis	0.000158	0.00109	CcSEcCtD
Nadolol—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000158	0.00109	CcSEcCtD
Nadolol—Paraesthesia—Prednisolone—ulcerative colitis	0.000158	0.00109	CcSEcCtD
Nadolol—Nausea—Azathioprine—ulcerative colitis	0.000158	0.00109	CcSEcCtD
Nadolol—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000156	0.00108	CcSEcCtD
Nadolol—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000156	0.00107	CcSEcCtD
Nadolol—Insomnia—Hydrocortisone—ulcerative colitis	0.000155	0.00107	CcSEcCtD
Nadolol—Hypertension—Dexamethasone—ulcerative colitis	0.000155	0.00107	CcSEcCtD
Nadolol—Hypertension—Betamethasone—ulcerative colitis	0.000155	0.00107	CcSEcCtD
Nadolol—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000154	0.00106	CcSEcCtD
Nadolol—Vomiting—Mesalazine—ulcerative colitis	0.000154	0.00106	CcSEcCtD
Nadolol—Rash—Mesalazine—ulcerative colitis	0.000152	0.00105	CcSEcCtD
Nadolol—Dermatitis—Mesalazine—ulcerative colitis	0.000152	0.00105	CcSEcCtD
Nadolol—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000151	0.00104	CcSEcCtD
Nadolol—Hypotension—Methylprednisolone—ulcerative colitis	0.000151	0.00104	CcSEcCtD
Nadolol—Pain—Prednisolone—ulcerative colitis	0.00015	0.00104	CcSEcCtD
Nadolol—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000149	0.00103	CcSEcCtD
Nadolol—Fatigue—Hydrocortisone—ulcerative colitis	0.000148	0.00102	CcSEcCtD
Nadolol—Vision blurred—Prednisone—ulcerative colitis	0.000148	0.00102	CcSEcCtD
Nadolol—Pain—Hydrocortisone—ulcerative colitis	0.000147	0.00101	CcSEcCtD
Nadolol—Oedema—Betamethasone—ulcerative colitis	0.000147	0.00101	CcSEcCtD
Nadolol—Oedema—Dexamethasone—ulcerative colitis	0.000147	0.00101	CcSEcCtD
Nadolol—Insomnia—Triamcinolone—ulcerative colitis	0.000146	0.00101	CcSEcCtD
Nadolol—Insomnia—Methylprednisolone—ulcerative colitis	0.000146	0.00101	CcSEcCtD
Nadolol—Paraesthesia—Triamcinolone—ulcerative colitis	0.000145	0.001	CcSEcCtD
Nadolol—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000145	0.000998	CcSEcCtD
Nadolol—Shock—Dexamethasone—ulcerative colitis	0.000144	0.000995	CcSEcCtD
Nadolol—Shock—Betamethasone—ulcerative colitis	0.000144	0.000995	CcSEcCtD
Nadolol—Dyspnoea—Triamcinolone—ulcerative colitis	0.000144	0.000993	CcSEcCtD
Nadolol—Nausea—Mesalazine—ulcerative colitis	0.000144	0.000988	CcSEcCtD
Nadolol—Dyspepsia—Triamcinolone—ulcerative colitis	0.000142	0.000981	CcSEcCtD
Nadolol—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000142	0.000979	CcSEcCtD
Nadolol—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000142	0.000977	CcSEcCtD
Nadolol—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000142	0.000977	CcSEcCtD
Nadolol—Syncope—Prednisone—ulcerative colitis	0.00014	0.000967	CcSEcCtD
Nadolol—Anorexia—Dexamethasone—ulcerative colitis	0.00014	0.000964	CcSEcCtD
Nadolol—Anorexia—Betamethasone—ulcerative colitis	0.00014	0.000964	CcSEcCtD
Nadolol—Fatigue—Triamcinolone—ulcerative colitis	0.00014	0.000961	CcSEcCtD
Nadolol—Fatigue—Methylprednisolone—ulcerative colitis	0.000139	0.000958	CcSEcCtD
Nadolol—Pain—Triamcinolone—ulcerative colitis	0.000138	0.000953	CcSEcCtD
Nadolol—Loss of consciousness—Prednisone—ulcerative colitis	0.000138	0.000948	CcSEcCtD
Nadolol—ADRB3—G alpha (s) signalling events—ADCY5—ulcerative colitis	0.000137	0.00826	CbGpPWpGaD
Nadolol—Hypotension—Betamethasone—ulcerative colitis	0.000137	0.000945	CcSEcCtD
Nadolol—Hypotension—Dexamethasone—ulcerative colitis	0.000137	0.000945	CcSEcCtD
Nadolol—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000136	0.000935	CcSEcCtD
Nadolol—Hypertension—Prednisone—ulcerative colitis	0.000135	0.000931	CcSEcCtD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000135	0.00811	CbGpPWpGaD
Nadolol—Insomnia—Dexamethasone—ulcerative colitis	0.000133	0.000914	CcSEcCtD
Nadolol—Insomnia—Betamethasone—ulcerative colitis	0.000133	0.000914	CcSEcCtD
Nadolol—ADRB1—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.000133	0.00798	CbGpPWpGaD
Nadolol—Paraesthesia—Betamethasone—ulcerative colitis	0.000132	0.000908	CcSEcCtD
Nadolol—Paraesthesia—Dexamethasone—ulcerative colitis	0.000132	0.000908	CcSEcCtD
Nadolol—Dyspepsia—Betamethasone—ulcerative colitis	0.000129	0.00089	CcSEcCtD
Nadolol—Dyspepsia—Dexamethasone—ulcerative colitis	0.000129	0.00089	CcSEcCtD
Nadolol—Body temperature increased—Triamcinolone—ulcerative colitis	0.000128	0.000881	CcSEcCtD
Nadolol—Oedema—Prednisone—ulcerative colitis	0.000128	0.00088	CcSEcCtD
Nadolol—Decreased appetite—Dexamethasone—ulcerative colitis	0.000128	0.000879	CcSEcCtD
Nadolol—Decreased appetite—Betamethasone—ulcerative colitis	0.000128	0.000879	CcSEcCtD
Nadolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000128	0.00767	CbGpPWpGaD
Nadolol—ADRB1—G alpha (s) signalling events—PTGER4—ulcerative colitis	0.000127	0.00762	CbGpPWpGaD
Nadolol—Fatigue—Betamethasone—ulcerative colitis	0.000127	0.000872	CcSEcCtD
Nadolol—Fatigue—Dexamethasone—ulcerative colitis	0.000127	0.000872	CcSEcCtD
Nadolol—Shock—Prednisone—ulcerative colitis	0.000126	0.000866	CcSEcCtD
Nadolol—Pain—Dexamethasone—ulcerative colitis	0.000126	0.000865	CcSEcCtD
Nadolol—Pain—Betamethasone—ulcerative colitis	0.000126	0.000865	CcSEcCtD
Nadolol—ADRB2—G alpha (s) signalling events—PTGER4—ulcerative colitis	0.000124	0.00745	CbGpPWpGaD
Nadolol—Hyperhidrosis—Prednisone—ulcerative colitis	0.000124	0.000851	CcSEcCtD
Nadolol—Asthenia—Hydrocortisone—ulcerative colitis	0.000123	0.000849	CcSEcCtD
Nadolol—ADRB2—Arf6 trafficking events—CDH1—ulcerative colitis	0.000123	0.00741	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000123	0.00739	CbGpPWpGaD
Nadolol—Anorexia—Prednisone—ulcerative colitis	0.000122	0.000839	CcSEcCtD
Nadolol—Pruritus—Hydrocortisone—ulcerative colitis	0.000122	0.000837	CcSEcCtD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.00012	0.00725	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CXCR1—ulcerative colitis	0.00012	0.00719	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000119	0.00714	CbGpPWpGaD
Nadolol—ADRB3—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	0.000118	0.00713	CbGpPWpGaD
Nadolol—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000118	0.00081	CcSEcCtD
Nadolol—Dizziness—Prednisolone—ulcerative colitis	0.000116	0.000801	CcSEcCtD
Nadolol—Asthenia—Triamcinolone—ulcerative colitis	0.000116	0.000799	CcSEcCtD
Nadolol—Body temperature increased—Dexamethasone—ulcerative colitis	0.000116	0.000799	CcSEcCtD
Nadolol—Body temperature increased—Betamethasone—ulcerative colitis	0.000116	0.000799	CcSEcCtD
Nadolol—Asthenia—Methylprednisolone—ulcerative colitis	0.000116	0.000798	CcSEcCtD
Nadolol—Insomnia—Prednisone—ulcerative colitis	0.000116	0.000796	CcSEcCtD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000116	0.00695	CbGpPWpGaD
Nadolol—Paraesthesia—Prednisone—ulcerative colitis	0.000115	0.000791	CcSEcCtD
Nadolol—Pruritus—Triamcinolone—ulcerative colitis	0.000114	0.000788	CcSEcCtD
Nadolol—Pruritus—Methylprednisolone—ulcerative colitis	0.000114	0.000787	CcSEcCtD
Nadolol—Dizziness—Hydrocortisone—ulcerative colitis	0.000114	0.000782	CcSEcCtD
Nadolol—Dyspepsia—Prednisone—ulcerative colitis	0.000113	0.000775	CcSEcCtD
Nadolol—Decreased appetite—Prednisone—ulcerative colitis	0.000111	0.000765	CcSEcCtD
Nadolol—Rash—Prednisolone—ulcerative colitis	0.000111	0.000764	CcSEcCtD
Nadolol—Dermatitis—Prednisolone—ulcerative colitis	0.000111	0.000763	CcSEcCtD
Nadolol—Diarrhoea—Methylprednisolone—ulcerative colitis	0.00011	0.000761	CcSEcCtD
Nadolol—Fatigue—Prednisone—ulcerative colitis	0.00011	0.000759	CcSEcCtD
Nadolol—Constipation—Prednisone—ulcerative colitis	0.000109	0.000753	CcSEcCtD
Nadolol—Vomiting—Hydrocortisone—ulcerative colitis	0.000109	0.000752	CcSEcCtD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000109	0.00655	CbGpPWpGaD
Nadolol—Rash—Hydrocortisone—ulcerative colitis	0.000108	0.000746	CcSEcCtD
Nadolol—Dermatitis—Hydrocortisone—ulcerative colitis	0.000108	0.000745	CcSEcCtD
Nadolol—Dizziness—Triamcinolone—ulcerative colitis	0.000107	0.000737	CcSEcCtD
Nadolol—Dizziness—Methylprednisolone—ulcerative colitis	0.000107	0.000735	CcSEcCtD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000106	0.0064	CbGpPWpGaD
Nadolol—Asthenia—Dexamethasone—ulcerative colitis	0.000105	0.000725	CcSEcCtD
Nadolol—Asthenia—Betamethasone—ulcerative colitis	0.000105	0.000725	CcSEcCtD
Nadolol—ADRB3—GPCR ligand binding—CCL20—ulcerative colitis	0.000105	0.00632	CbGpPWpGaD
Nadolol—Nausea—Prednisolone—ulcerative colitis	0.000105	0.00072	CcSEcCtD
Nadolol—Pruritus—Dexamethasone—ulcerative colitis	0.000104	0.000715	CcSEcCtD
Nadolol—Pruritus—Betamethasone—ulcerative colitis	0.000104	0.000715	CcSEcCtD
Nadolol—Vomiting—Triamcinolone—ulcerative colitis	0.000103	0.000708	CcSEcCtD
Nadolol—Vomiting—Methylprednisolone—ulcerative colitis	0.000103	0.000707	CcSEcCtD
Nadolol—Nausea—Hydrocortisone—ulcerative colitis	0.000102	0.000703	CcSEcCtD
Nadolol—Rash—Triamcinolone—ulcerative colitis	0.000102	0.000703	CcSEcCtD
Nadolol—Dermatitis—Triamcinolone—ulcerative colitis	0.000102	0.000702	CcSEcCtD
Nadolol—Rash—Methylprednisolone—ulcerative colitis	0.000102	0.000701	CcSEcCtD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000102	0.00612	CbGpPWpGaD
Nadolol—Dermatitis—Methylprednisolone—ulcerative colitis	0.000102	0.0007	CcSEcCtD
Nadolol—Body temperature increased—Prednisone—ulcerative colitis	0.000101	0.000696	CcSEcCtD
Nadolol—Diarrhoea—Dexamethasone—ulcerative colitis	0.0001	0.000692	CcSEcCtD
Nadolol—Diarrhoea—Betamethasone—ulcerative colitis	0.0001	0.000692	CcSEcCtD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	9.8e-05	0.0059	CbGpPWpGaD
Nadolol—Dizziness—Betamethasone—ulcerative colitis	9.71e-05	0.000669	CcSEcCtD
Nadolol—Dizziness—Dexamethasone—ulcerative colitis	9.71e-05	0.000669	CcSEcCtD
Nadolol—ADRB1—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	9.69e-05	0.00583	CbGpPWpGaD
Nadolol—Nausea—Triamcinolone—ulcerative colitis	9.61e-05	0.000662	CcSEcCtD
Nadolol—ADRB1—G alpha (s) signalling events—ADRB2—ulcerative colitis	9.6e-05	0.00577	CbGpPWpGaD
Nadolol—Nausea—Methylprednisolone—ulcerative colitis	9.59e-05	0.00066	CcSEcCtD
Nadolol—ADRB2—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	9.48e-05	0.00571	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CXCR2—ulcerative colitis	9.36e-05	0.00563	CbGpPWpGaD
Nadolol—Vomiting—Dexamethasone—ulcerative colitis	9.33e-05	0.000643	CcSEcCtD
Nadolol—Vomiting—Betamethasone—ulcerative colitis	9.33e-05	0.000643	CcSEcCtD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	9.32e-05	0.00561	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	9.31e-05	0.0056	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	9.3e-05	0.00559	CbGpPWpGaD
Nadolol—Rash—Betamethasone—ulcerative colitis	9.26e-05	0.000637	CcSEcCtD
Nadolol—Rash—Dexamethasone—ulcerative colitis	9.26e-05	0.000637	CcSEcCtD
Nadolol—Dermatitis—Betamethasone—ulcerative colitis	9.25e-05	0.000637	CcSEcCtD
Nadolol—Dermatitis—Dexamethasone—ulcerative colitis	9.25e-05	0.000637	CcSEcCtD
Nadolol—Asthenia—Prednisone—ulcerative colitis	9.17e-05	0.000632	CcSEcCtD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	9.12e-05	0.00549	CbGpPWpGaD
Nadolol—Pruritus—Prednisone—ulcerative colitis	9.05e-05	0.000623	CcSEcCtD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	9e-05	0.00541	CbGpPWpGaD
Nadolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	8.89e-05	0.00535	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CCR6—ulcerative colitis	8.8e-05	0.00529	CbGpPWpGaD
Nadolol—Diarrhoea—Prednisone—ulcerative colitis	8.75e-05	0.000602	CcSEcCtD
Nadolol—Nausea—Betamethasone—ulcerative colitis	8.72e-05	0.000601	CcSEcCtD
Nadolol—Nausea—Dexamethasone—ulcerative colitis	8.72e-05	0.000601	CcSEcCtD
Nadolol—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	8.65e-05	0.0052	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	8.51e-05	0.00512	CbGpPWpGaD
Nadolol—Dizziness—Prednisone—ulcerative colitis	8.45e-05	0.000582	CcSEcCtD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	8.33e-05	0.00501	CbGpPWpGaD
Nadolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	8.29e-05	0.00498	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	8.18e-05	0.00492	CbGpPWpGaD
Nadolol—ADRB1—G alpha (s) signalling events—ADCY5—ulcerative colitis	8.15e-05	0.0049	CbGpPWpGaD
Nadolol—Vomiting—Prednisone—ulcerative colitis	8.13e-05	0.00056	CcSEcCtD
Nadolol—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	8.13e-05	0.00489	CbGpPWpGaD
Nadolol—Rash—Prednisone—ulcerative colitis	8.06e-05	0.000555	CcSEcCtD
Nadolol—Dermatitis—Prednisone—ulcerative colitis	8.05e-05	0.000555	CcSEcCtD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	8.01e-05	0.00482	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	8e-05	0.00482	CbGpPWpGaD
Nadolol—ADRB2—G alpha (s) signalling events—ADCY5—ulcerative colitis	7.97e-05	0.00479	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	7.83e-05	0.00471	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—PTGER4—ulcerative colitis	7.75e-05	0.00466	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	7.71e-05	0.00464	CbGpPWpGaD
Nadolol—Nausea—Prednisone—ulcerative colitis	7.59e-05	0.000523	CcSEcCtD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	7.29e-05	0.00439	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	7.16e-05	0.0043	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	7.14e-05	0.00429	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CXCR1—ulcerative colitis	7.1e-05	0.00427	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—GHRL—ulcerative colitis	7.09e-05	0.00427	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	7.05e-05	0.00424	CbGpPWpGaD
Nadolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	7.03e-05	0.00423	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CXCR1—ulcerative colitis	6.94e-05	0.00418	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	6.89e-05	0.00415	CbGpPWpGaD
Nadolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	6.88e-05	0.00414	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	6.86e-05	0.00413	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CXCR1—ulcerative colitis	6.76e-05	0.00407	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	6.71e-05	0.00404	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL10—ulcerative colitis	6.32e-05	0.0038	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCL20—ulcerative colitis	6.23e-05	0.00375	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CXCR1—ulcerative colitis	6.14e-05	0.00369	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCL20—ulcerative colitis	6.1e-05	0.00367	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	6.04e-05	0.00363	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	6.04e-05	0.00363	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CCL20—ulcerative colitis	5.93e-05	0.00357	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	5.91e-05	0.00355	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—ADRB2—ulcerative colitis	5.87e-05	0.00353	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—GNA12—ulcerative colitis	5.58e-05	0.00336	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CXCR2—ulcerative colitis	5.55e-05	0.00334	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	5.53e-05	0.00333	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CXCR2—ulcerative colitis	5.43e-05	0.00327	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	5.41e-05	0.00325	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCL20—ulcerative colitis	5.39e-05	0.00324	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	5.34e-05	0.00321	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CXCR2—ulcerative colitis	5.29e-05	0.00318	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCR6—ulcerative colitis	5.22e-05	0.00314	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	5.15e-05	0.0031	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCR6—ulcerative colitis	5.11e-05	0.00307	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	5.09e-05	0.00306	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—GNA12—ulcerative colitis	5.07e-05	0.00305	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CCR6—ulcerative colitis	4.97e-05	0.00299	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CXCR2—ulcerative colitis	4.8e-05	0.00289	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—PTGER4—ulcerative colitis	4.6e-05	0.00277	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	4.58e-05	0.00275	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCR6—ulcerative colitis	4.52e-05	0.00272	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—PTGER4—ulcerative colitis	4.5e-05	0.00271	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—SEL1L—ulcerative colitis	4.4e-05	0.00265	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—PTGER4—ulcerative colitis	4.38e-05	0.00263	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—GHRL—ulcerative colitis	4.21e-05	0.00253	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—GHRL—ulcerative colitis	4.12e-05	0.00248	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCR1—ulcerative colitis	4.01e-05	0.00241	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—GHRL—ulcerative colitis	4.01e-05	0.00241	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—PTGER4—ulcerative colitis	3.98e-05	0.00239	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCR1—ulcerative colitis	3.92e-05	0.00236	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	3.72e-05	0.00224	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	3.72e-05	0.00224	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCR1—ulcerative colitis	3.64e-05	0.00219	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—GHRL—ulcerative colitis	3.64e-05	0.00219	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCR1—ulcerative colitis	3.63e-05	0.00218	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCR1—ulcerative colitis	3.56e-05	0.00214	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	3.56e-05	0.00214	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	3.56e-05	0.00214	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CALM3—ulcerative colitis	3.52e-05	0.00212	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CCL20—ulcerative colitis	3.52e-05	0.00212	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—ADRB2—ulcerative colitis	3.48e-05	0.0021	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	3.46e-05	0.00208	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CCL20—ulcerative colitis	3.45e-05	0.00207	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—ADRB2—ulcerative colitis	3.32e-05	0.002	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	3.32e-05	0.00199	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—GNA12—ulcerative colitis	3.31e-05	0.00199	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL2—ulcerative colitis	3.3e-05	0.00199	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—GNA12—ulcerative colitis	3.24e-05	0.00195	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL20—ulcerative colitis	3.2e-05	0.00192	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL20—ulcerative colitis	3.18e-05	0.00191	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCR2—ulcerative colitis	3.14e-05	0.00189	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL20—ulcerative colitis	3.13e-05	0.00188	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCR2—ulcerative colitis	3.07e-05	0.00185	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—ADRB2—ulcerative colitis	3.01e-05	0.00181	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—GNA12—ulcerative colitis	3.01e-05	0.00181	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—GNA12—ulcerative colitis	2.99e-05	0.0018	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CCR6—ulcerative colitis	2.95e-05	0.00178	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—GNA12—ulcerative colitis	2.94e-05	0.00177	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CCR6—ulcerative colitis	2.89e-05	0.00174	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCR2—ulcerative colitis	2.85e-05	0.00171	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCR2—ulcerative colitis	2.84e-05	0.00171	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CXCL8—ulcerative colitis	2.84e-05	0.00171	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—ADCY5—ulcerative colitis	2.82e-05	0.00169	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCR2—ulcerative colitis	2.79e-05	0.00168	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCR6—ulcerative colitis	2.68e-05	0.00161	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCR6—ulcerative colitis	2.67e-05	0.0016	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCR6—ulcerative colitis	2.62e-05	0.00158	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SEL1L—ulcerative colitis	2.61e-05	0.00157	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—PTGER4—ulcerative colitis	2.6e-05	0.00156	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	2.58e-05	0.00155	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—ADCY5—ulcerative colitis	2.56e-05	0.00154	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SEL1L—ulcerative colitis	2.56e-05	0.00154	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—PTGER4—ulcerative colitis	2.54e-05	0.00153	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MAML2—ulcerative colitis	2.53e-05	0.00152	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—TNF—ulcerative colitis	2.41e-05	0.00145	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—GHRL—ulcerative colitis	2.38e-05	0.00143	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—PTGER4—ulcerative colitis	2.36e-05	0.00142	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PTGER4—ulcerative colitis	2.35e-05	0.00141	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—GHRL—ulcerative colitis	2.33e-05	0.0014	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—PTGER4—ulcerative colitis	2.31e-05	0.00139	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.22e-05	0.00133	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.21e-05	0.00133	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.16e-05	0.0013	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—GHRL—ulcerative colitis	2.16e-05	0.0013	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCR1—ulcerative colitis	2.15e-05	0.00129	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—GHRL—ulcerative colitis	2.15e-05	0.00129	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—GHRL—ulcerative colitis	2.11e-05	0.00127	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCR1—ulcerative colitis	2.11e-05	0.00127	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CALM3—ulcerative colitis	2.09e-05	0.00126	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CALM3—ulcerative colitis	2.08e-05	0.00125	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—RIPK2—ulcerative colitis	2.05e-05	0.00123	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CALM3—ulcerative colitis	2.05e-05	0.00123	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CHP1—ulcerative colitis	2.05e-05	0.00123	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—ADRB2—ulcerative colitis	1.97e-05	0.00118	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL20—ulcerative colitis	1.89e-05	0.00114	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL20—ulcerative colitis	1.85e-05	0.00111	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—ADRB2—ulcerative colitis	1.79e-05	0.00108	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ADRB2—ulcerative colitis	1.78e-05	0.00107	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GNA12—ulcerative colitis	1.78e-05	0.00107	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—DLD—ulcerative colitis	1.77e-05	0.00106	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.76e-05	0.00106	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—JAK2—ulcerative colitis	1.76e-05	0.00106	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GNA12—ulcerative colitis	1.74e-05	0.00105	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCR2—ulcerative colitis	1.68e-05	0.00101	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CXCL8—ulcerative colitis	1.68e-05	0.00101	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—ADCY5—ulcerative colitis	1.67e-05	0.00101	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCR2—ulcerative colitis	1.65e-05	0.000991	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CXCL8—ulcerative colitis	1.65e-05	0.00099	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—ADCY5—ulcerative colitis	1.64e-05	0.000984	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CXCL8—ulcerative colitis	1.6e-05	0.000964	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—JAK2—ulcerative colitis	1.59e-05	0.000959	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCR6—ulcerative colitis	1.58e-05	0.000952	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCR6—ulcerative colitis	1.55e-05	0.000932	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—IL2—ulcerative colitis	1.53e-05	0.000921	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.53e-05	0.000918	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—ADCY5—ulcerative colitis	1.52e-05	0.000913	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ADCY5—ulcerative colitis	1.51e-05	0.000909	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MAML2—ulcerative colitis	1.5e-05	0.000903	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—ADCY5—ulcerative colitis	1.48e-05	0.000893	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MAML2—ulcerative colitis	1.47e-05	0.000883	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CXCL8—ulcerative colitis	1.46e-05	0.000875	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PTGER4—ulcerative colitis	1.39e-05	0.000839	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL2—ulcerative colitis	1.39e-05	0.000837	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PTGER4—ulcerative colitis	1.36e-05	0.00082	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GHRL—ulcerative colitis	1.28e-05	0.000768	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.27e-05	0.000765	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GHRL—ulcerative colitis	1.25e-05	0.000751	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CALM3—ulcerative colitis	1.24e-05	0.000744	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—RIPK2—ulcerative colitis	1.22e-05	0.000732	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CALM3—ulcerative colitis	1.21e-05	0.000727	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—RIPK2—ulcerative colitis	1.19e-05	0.000716	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.19e-05	0.000716	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.19e-05	0.000714	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ADRB2—ulcerative colitis	1.06e-05	0.000635	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.05e-05	0.00063	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—JAK2—ulcerative colitis	1.04e-05	0.000627	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—JAK2—ulcerative colitis	1.02e-05	0.000613	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCL8—ulcerative colitis	9.51e-06	0.000572	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—JAK2—ulcerative colitis	9.46e-06	0.000569	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—JAK2—ulcerative colitis	9.42e-06	0.000567	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCL8—ulcerative colitis	9.3e-06	0.00056	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—JAK2—ulcerative colitis	9.26e-06	0.000557	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—RELA—ulcerative colitis	9.12e-06	0.000549	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—IL2—ulcerative colitis	9.09e-06	0.000547	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ADCY5—ulcerative colitis	8.97e-06	0.000539	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—IL2—ulcerative colitis	8.89e-06	0.000535	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ADCY5—ulcerative colitis	8.77e-06	0.000528	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCL8—ulcerative colitis	8.64e-06	0.00052	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCL8—ulcerative colitis	8.6e-06	0.000517	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PTGS1—ulcerative colitis	8.53e-06	0.000513	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCL8—ulcerative colitis	8.45e-06	0.000508	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL2—ulcerative colitis	8.25e-06	0.000497	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL2—ulcerative colitis	8.21e-06	0.000494	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL6—ulcerative colitis	8.17e-06	0.000492	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL2—ulcerative colitis	8.07e-06	0.000486	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.98e-06	0.00048	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MMP9—ulcerative colitis	7.77e-06	0.000468	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NFKB1—ulcerative colitis	7.69e-06	0.000463	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CALM3—ulcerative colitis	7.68e-06	0.000462	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—STAT3—ulcerative colitis	6.91e-06	0.000416	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TGFB1—ulcerative colitis	6.41e-06	0.000385	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—JAK2—ulcerative colitis	5.59e-06	0.000336	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ADCY5—ulcerative colitis	5.57e-06	0.000335	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—JAK2—ulcerative colitis	5.47e-06	0.000329	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—RELA—ulcerative colitis	5.41e-06	0.000326	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—RELA—ulcerative colitis	5.3e-06	0.000319	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TP53—ulcerative colitis	5.27e-06	0.000317	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCL8—ulcerative colitis	5.1e-06	0.000307	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL8—ulcerative colitis	4.99e-06	0.0003	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL2—ulcerative colitis	4.88e-06	0.000293	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL6—ulcerative colitis	4.85e-06	0.000292	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL6—ulcerative colitis	4.83e-06	0.00029	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL2—ulcerative colitis	4.77e-06	0.000287	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL6—ulcerative colitis	4.75e-06	0.000285	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MMP9—ulcerative colitis	4.61e-06	0.000278	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NFKB1—ulcerative colitis	4.57e-06	0.000275	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MMP9—ulcerative colitis	4.51e-06	0.000272	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NFKB1—ulcerative colitis	4.47e-06	0.000269	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPARG—ulcerative colitis	4.16e-06	0.00025	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—STAT3—ulcerative colitis	4.1e-06	0.000247	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—STAT3—ulcerative colitis	4.01e-06	0.000241	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TGFB1—ulcerative colitis	3.8e-06	0.000229	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ALB—ulcerative colitis	3.74e-06	0.000225	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TGFB1—ulcerative colitis	3.72e-06	0.000224	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PTGS2—ulcerative colitis	3.27e-06	0.000197	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TP53—ulcerative colitis	3.13e-06	0.000188	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TP53—ulcerative colitis	3.06e-06	0.000184	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL6—ulcerative colitis	2.87e-06	0.000172	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL6—ulcerative colitis	2.8e-06	0.000169	CbGpPWpGaD
